The short version.
If you read nothing else, read this. The whole guide in a handful of bullets.
- What it is: Larazotide is a synthetic eight-amino-acid peptide that works at the gut lining as a zonulin antagonist, helping the tight junctions between intestinal cells stay closed.
- What people run it for: leaky gut and intestinal barrier support; in clinical trials it was studied for celiac disease symptoms despite a gluten-free diet.
- Typical dose: about 0.5 mg (500 mcg) by mouth three times a day, each dose roughly 15 minutes before a meal.
- Routes: oral capsule only. It is taken by mouth, with no injection and no reconstitution.
- Course: taken consistently each day, before meals; the effect builds over weeks rather than from a single dose.
- Honest caveat: the real human data is from celiac trials, where it met a Phase 2b endpoint but its Phase 3 study was discontinued in 2022. It was never approved and is sold for research use only. This is not medical advice.
Quick reference.
| Typical dose | 0.5 mg (500 mcg), three times daily |
|---|---|
| Routes | Oral capsule, taken before meals |
| Frequency | Three times a day, ~15 minutes before each meal |
| Cycle length | A daily course; effect builds over weeks |
| Best for | Leaky gut and intestinal barrier support |
What is Larazotide?
Larazotide is a short peptide, which simply means a small chain of amino acids, the same building blocks that make up the proteins in your body. It is made up of just eight of them, which makes it one of the smaller peptides people talk about.
Its structure is derived from zonula occludens toxin, a bacterial molecule that loosens the junctions between gut cells. Larazotide was designed to do the opposite: to act as a zonulin antagonist, blocking the body's own signal that pries those junctions open, so the gut barrier stays tighter.
The version sold by vendors usually arrives as an oral capsule or as a powder meant to be taken by mouth. It is not a steroid, not a hormone, and not a stimulant. People reach for it for one theme above all: supporting the integrity of the gut lining, the so-called leaky gut idea.
Worth saying plainly: Larazotide is not an approved medicine anywhere. Its most advanced testing was for celiac disease, where it met an earlier endpoint but then had its Phase 3 trial discontinued in 2022. It is sold strictly for research use only, and broader leaky-gut use is largely extrapolation. We get into what that means further down.
How it works in the body.
You do not need a biology degree to follow this. Here is the simple picture, then a little more for the curious.
The core idea is that your gut lining is held together by tight junctions, like grout between tiles. A signal called zonulin can loosen that grout. Larazotide is studied for getting in the way of that signal so the barrier stays sealed.
- Zonulin antagonism. Zonulin is the body's own molecule that opens the tight junctions between gut cells. Larazotide competes with it, which is studied for keeping those junctions closed and reducing what slips through the gut wall.
- Tight-junction support. It has been linked to the rearrangement of tight-junction proteins and actin filaments back into a sealed arrangement, helping restore the barrier rather than just blocking a single step.
- Local, gut-restricted action. It works inside the gut and is barely absorbed into the bloodstream. That is by design: it sits where the barrier problem is instead of circulating body-wide, which also limits systemic side effects.
How to take it: routes of administration.
Larazotide is an oral peptide, full stop. Unlike injectable peptides there is no needle and nothing to choose between routes; the only real variable is timing around meals. Here is the honest comparison.
| Route | Typical dose | Absorption | Best for | Difficulty |
|---|---|---|---|---|
| Oral (capsule) | 0.5 mg | Acts locally in gut | Standard, before meals | Easy, no needles |
| Sublingual | Not established | Unproven | Not how it was studied | No trial basis |
| Injection | Not used | Pointless | Not applicable | Defeats its local action |
Oral capsule
The only route that matters and the one every trial used. A capsule by mouth, taken about 15 minutes before eating, three times a day. Because Larazotide is meant to work right at the gut lining and is barely absorbed into the blood, oral is not a compromise, it is the whole point.
Sublingual
You may see sublingual ideas floated, but Larazotide was never studied that way and its action depends on reaching the gut lumen. There is no trial basis for it, so it is not a route worth chasing.
Injection
Injecting Larazotide would put it into the bloodstream, which is the opposite of what it is designed to do. Its whole mechanism is local, inside the gut, so an injectable form would defeat the purpose. Nobody runs it this way.
So which should a beginner pick? There is really only one option: oral, before meals. The thing to get right is not the route but the timing and consistency, taking each dose roughly 15 minutes before eating, three times a day.
Dosing by goal.
There is no single official dose for Larazotide, because it is not an approved medicine. What follows is the regimen used in its clinical trials, which is where the real numbers come from. The defining feature of Larazotide dosing is the pre-meal, three-times-a-day pattern.
Standard dose
The dose carried into Phase 3 was 0.5 mg (500 mcg) taken three times a day. Interestingly, in the trials the lower 0.5 mg dose worked better than higher doses, so more is not better here.
Timing around meals
Each dose was taken about 15 minutes before a meal, so the peptide is already at the gut lining when food and any triggers arrive. This pre-meal timing is the part people most often get wrong.
Stacked with gut peptides
When run alongside BPC-157 or KPV, the Larazotide schedule stays the same, three pre-meal doses a day. The partner peptides keep their own rhythms, so the two simply overlap within the same daily routine.
Three oral doses a day, each about 15 minutes before a meal. The lower 0.5 mg dose outperformed higher ones in trials, so there is no reason to push it up.
Take each dose roughly a quarter hour before eating so it is in place when food arrives. Consistency matters more than precision to the minute.
Cycling and timing.
A cycle just means a defined run of time on the peptide. Larazotide was studied as a daily, ongoing therapy rather than something taken in short loading blocks, so people tend to run it as a steady daily course while they are working on gut symptoms.
Why not just run it forever? Mostly because the long-term human safety data does not exist outside the trial windows, and it never reached approval. The cautious approach is to run a defined course, reassess, and not assume indefinite use is fine.
- Hold the schedule at three pre-meal doses a day rather than skipping around.
- Reassess after a defined block instead of running it open-endedly, since long-term data is thin.
- Loop in a provider if gut symptoms are significant or persistent. Real gut disease deserves a real workup, not just a peptide.
Stacking Larazotide.
Larazotide is a gut-barrier peptide, so it stacks with other gut-and-healing compounds rather than the injectable recovery blends people pair with TB-500.
Leaky-gut support
The pairing people reach for when the gut lining is the target. BPC-157 is run for repair of the gut wall itself, while Larazotide is studied for keeping the tight junctions closed from inside the lumen. Two different angles on the same barrier.
View stack →Barrier, repair & calm
The all-in-on-the-gut option. It layers barrier support, tissue repair, and the anti-inflammatory angle of KPV into one daily routine. A step up for people who want to cover the whole gut picture at once.
View stack →See full recipes, dosing, and how people run them on the stacks page.
Side effects and safety.
In the trials we have, Larazotide was generally described as well tolerated, with a side-effect profile close to placebo. That partly reflects how little of it reaches the bloodstream. The effects people mention most often are:
- Headache, the most commonly reported effect, and one that also showed up in placebo groups.
- Fatigue or tiredness, reported by some participants.
- Mild digestive symptoms, such as bloating or changes in stool, in a minority of people.
- Nasal or throat irritation noted in some trial reports, generally minor.
Who should be cautious.
Some people have clear reasons to be extra careful, or to avoid Larazotide entirely until they have spoken with a licensed provider.
- Pregnant or breastfeeding. There is no safety data here, so this is a hard avoid.
- Suspected celiac or serious gut disease. These need a real diagnosis and a gluten-free diet or proper treatment, not a research peptide as a substitute. See a gastroenterologist.
- Children. Trial dosing in younger, lighter participants differed, and this is not a self-experiment to run on kids.
- Anyone on other medications. If you take prescription drugs or manage a chronic condition, talk to your provider first.
And the universal one: whoever you are, talk to a licensed healthcare provider before starting Larazotide. This guide is educational, not a substitute for personalized medical advice.
Where to buy it safely.
This is where a lot of beginners get burned, because peptide quality varies wildly between vendors and the cheapest product is not always the real deal. Our honest take: do not shop on price alone, shop on price plus independent lab data.
- Compare vendors side by side. Price ranges are wide, and the difference between the lowest and highest listing can be large for the exact same compound.
- Look for recent third-party lab tests. The gold standard the community looks for is a recent Janoshik certificate of analysis showing purity for the batch you are actually buying.
- Favor recent COAs. An old lab result on a different batch tells you little. The fresher the test, the more it means.
- Be skeptical of suspiciously cheap listings with no testing behind them.
That is exactly the comparison we put together. On our Larazotide product page you can compare vendor prices, see which batches have public lab data, and view the grades we assign from that data. From there you can head to the buy page to line up your options.
Questions, answered straight.
Is Larazotide legal?
Larazotide is not an approved drug and is not sold for human use. The vendors we compare offer it strictly for research use only. It is not a known performance-enhancing substance, but rules vary by country, so check what applies where you are.
What is Larazotide actually for?
Its real testing was for celiac disease, helping reduce symptoms in people who still reacted despite a gluten-free diet. People outside that setting run it for general leaky-gut and gut-barrier support, which is an extrapolation rather than a proven use.
Why did its development stop?
Larazotide reached Phase 3, the furthest any celiac drug had gone, but the CedLara trial was discontinued in 2022 because the benefit was not clear enough to continue feasibly. It met an earlier Phase 2b endpoint but never crossed the finish line to approval.
With or without food?
Before food. The trial protocol was to take each dose about 15 minutes before a meal so it is acting at the gut lining when food arrives. That pre-meal timing is central to how Larazotide is run.
Do I need to inject or reconstitute it?
No. Larazotide is an oral capsule. There is no bacteriostatic water, no syringe, and no injection sites. You swallow it before meals, which is part of why people find it more approachable than injectable peptides.
How long until it works?
It is not an overnight switch. In the trials it was taken three times a day and any benefit built over weeks of consistent dosing. Treat it as a daily course rather than something you feel right away.